Back to Browse Journals
Neuropsychiatric Disease and Treatment
Pharma, Independent Pharma Consultant, United Kingdom
Editor-in-Chief: Dr Roger M. Pinder, PhD, DSc
Dr Pinder is an independent pharma consultant based in the city of York in the UK. He advises and consults worldwide to several pharmaceutical and venture capital organizations. He is founding editor of Neuropsychiatric Disease and Treatment and of the International Journal of Wine Research. He has served as president and secretary of the International Society for Affective Disorders (ISAD), and as treasurer and councillor of the International College of Neuropsychopharmacology (CINP).
Educated in the UK and the USA at the universities of Hull and Virginia, Dr Pinder holds doctoral degrees in medicinal chemistry (PhD) and neuropsychopharmacology (DSc). He is a fellow of the British Pharmacological Society, the British Association for Psychopharmacology, the European (ECNP) and the International Colleges of Neuropsychopharmacology (CINP), and of ISAD, and serves on the editorial board of Medicinal Chemistry Research. His professional research interests include cardiovascular and CNS pharmacology and therapeutics, with a special emphasis on depressive disorders, anti-depressants and the health benefits of wine. He is a regular speaker and chair at international congresses, and has published five books and more than 250 review and research articles.
After a long career in R&D and medical affairs management in the international pharmaceutical industry, DrPinder is now a board member of a number of start-up pharmaceutical companies.
Department of Psychiatry, Fujita Health University School of Medicine, Japan
Associate Editor - Japan: Dr Taro Kishi
Dr. Kishi has been practicing at the Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan, since 2002. In 2010 and 2011, he spent two years as a postdoctoral research fellow at the Zucker Hillside Hospital in New York. Dr. Kishi is a senior lecturer at the Department of Psychiatry, Fujita Health University School of Medicine. Dr. Kishi has been performing a series of clinical trials for the treatment of schizophrenia and mood disorder. His research focus is also evidence-based medicine in schizophrenia and mood disorder with a focus on meta-analyses. Moreover, He has a research interest in psychiatric genetics, pharmacogenetics, compliance enhancement strategies and medical decision making. He has authored/co-authored more than 120 articles.
Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong
Associate Editor - China: Professor Wai Kwong Tang
Professor WK Tang was appointed to Professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong, he then joined the Chinese University of Hong Kong as an academic staff in 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.
Hojjat Adeli, Abba G Lichtenstein Professor, The Ohio State University, Columbus, OH, USA
Kristian Barlinn, Department of Neurology, University Hospital Carl Gustav Carus, Dresden, Germany
Marlene Oscar Berman, Professor of Psychiatry, Neurology, Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA
Mike Briley, NeuroBiz Consulting and Communications, Castres, France
Joseph R Calabrese, Professor of Psychiatry, Case Western Reserve University, Cleveland, USA
Sandra Chan, Associate Professor, Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong
Dr. Lin Chen, MD. & Ph.D. Associate Chief Physician, Department of Neurosurgery, Tsinghua University and Yuquan Hospital, People’s Republic of China
Wai-Tong Chien, Professor and Associate Head (Research), School of Nursing, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong SAR
Francesco Craig, Child Neuropsychiatry Unit, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari “Aldo Moro”, Italy
Anthony David, Professor of Cognitive Neuropsychiatry, Kings College, London, UK
Andrea Fagiolini, Professor of Psychiatry, Chairman, Department of Mental Health, University of Siena School of Medicine, Italy
Mike Isaac, Consultant and Hon Senior Lecturer in Psychiatry, South London & Maudsley NHS FT and University of London, UK
Prof. Dr. IZNAK
Andrey Iznak, Professor, Mental Health Research Centre, Moscow, Russia
Sidney H Kennedy, Professor and Arthur Sommer Rotenberg Chair in Suicide and Depression Studies, St. Michael’s Hospital, Canada
Firas Kobeissy, Asst Rsrch Prof, Assoc Scientific Dir of Psychoproteomics & Nanotechnology Rsrch Ctr, Dept of Psychiatry, The Evelyn F & William L McKnight Brain Institute, University of Florida, Gainesville, FL, USA
Michael Krausz, Professor, Department of Psychiatry, The University of British Columbia, Vancouver, BC, Canada
John S Markowitz, Professor, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, FL, USA
Peter R. Martin, M.D., Professor of Psychiatry and Behavioral Sciences, Professor of Pharmacology, Vanderbilt Psychiatric Hospital, Vanderbilt University School of Medicine, Nashville, TN, USA
Julien Mendlewicz, Professor, Free University of Brussels, Brussels, Belgium
Shinichi Mitsui, Professor, Department of Rehabilitation Sciences, Gunma University Graduate School of Health Sciences, Gunma, Japan
Zoran M Pavlovic, CEO, Neuropassion KG, Heidelberg, Germany
George Perry, Dean, College of Sciences, University of Texas at San Antonio, San Antonio, TX, USA
Norman Sartorius, MD, PhD, FRCpsych, President, Association for the Improvement of Mental Health Programmes, Switzerland
Alessandro Serretti, MD, PhD, Department of Biomedical and NeuroMotor Sciences, University of Bologna, Italy
Haowei Shen, Ph.D., National Institute on Drug Dependence, Peking University, Beijing, People's Republic of China
Timo Siepmann, Research Physician, Department of Neurology, University Hospital Carl Gustav Carus; Program Director, Master's Program in Clinical Research, Dresden International University; Postdoctoral Researcher, Oxford Cardiovascular Clinical Research Facility, University of Oxford, Oxford, United Kingdom;
Edoardo Spina, Professor of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Eduard Vieta, Professor and Director of Research, Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, Spain
Ng Beng Yeong, Department of Psychiatry, Singapore General Hospital, Singapore
Nathan Zasler, Clinical Professor, Department of PM&R, Virginia Commonwealth University, and Clinical Associate Professor, Department of PM&R, University of Virginia, Charlottesville, Virginia, USA